Antifungal prophylaxis is effective against murine invasive pulmonary aspergillosis.
Rieg
Gunter
G
Spellberg
Brad
B
Schwartz
Julie
J
Fu
Yue
Y
Edwards
John E
JE
Sheppard
Donald C
DC
Ibrahim
Ashraf S
AS
D000666:Amphotericin B / Q000008:administration & dosage* / Q000627:therapeutic use; D000818:Animals; D000935:Antifungal Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D001228:Aspergillosis / Q000517:prevention & control*; D001232:Aspergillus fumigatus / Q000187:drug effects; D004334:Drug Administration Schedule; D004338:Drug Combinations; D007275:Injections, Intravenous; D008172:Lung Diseases, Fungal / Q000188:drug therapy* / Q000382:microbiology / Q000473:pathology / Q000517:prevention & control*; D051379:Mice; D008807:Mice, Inbred BALB C; D010456:Peptides, Cyclic / Q000008:administration & dosage / Q000627:therapeutic use; D010713:Phosphatidylcholines / Q000008:administration & dosage / Q000627:therapeutic use; D010715:Phosphatidylglycerols / Q000008:administration & dosage / Q000627:therapeutic use; D013997:Time Factors
D000935:Antifungal Agents; D004338:Drug Combinations; D010456:Peptides, Cyclic; D010713:Phosphatidylcholines; D010715:Phosphatidylglycerols; C068538:liposomal amphotericin B; D000666:Amphotericin B